Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules

Cancer

Volumn 47, Issue 10, 1981, Pages 2327-2345

  Miller, Elizabeth C ^a   Miller, James A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN; RNA;

CHEMICAL CARCINOGENESIS; ETIOLOGY; INJURY; MACROMOLECULE; SHORT SURVEY;

2-ACETYLAMINOFLUORENE; AFLATOXINS; ANIMAL; ANISOLES; BIOTRANSFORMATION; CARCINOGENS; CHEMISTRY; COCARCINOGENESIS; DNA; HUMAN; LIVER; MACROMOLECULAR SYSTEMS; NEOPLASMS; RATS; SAFROLE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0019519171     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19810515)47:10<2327::AID-CNCR2820471003>3.0.CO;2-Z     Document Type: Article

References (222)

1. Carcinogenesis and inhibition of the Walker 256 tumor in the rat by trans‐ 4‐acetylamino‐stilbene, its N‐hydroxy metabolite, and related compounds
2. Studies on the mutagenicity of N‐hydroxy‐2‐acetylaminofluorene in the Ames‐Salmonella mutagenesis test system
3. Studies on the formation of hydrocarbon‐deoxyribonucleoside products by the binding of derivatives of 7‐methylbenz[a]anthracene to DNA in aqueous solution and in mouse embryo cells in culture
4. Electrophilic N‐acetoxyaminoarenes derived from carcinogenic N‐hydroxy‐N‐ acetylaminoarenes by enzymatic deacetylation and transacetylation in liver
5. On the metabolic activation of the carcinogen N‐hyroxy‐N‐2‐acetylaminofluorene. III. Oxidation with horseradish peroxidase to yield 2‐nitrosofluorene and N‐acetoxy‐N‐2‐acetylaminoflurene
6. Characterization of DNA adducts of the carcinogen N‐methyl‐4‐ aminoazobenzene in vitro and in vivo
7. Increase of NAD(P)H: quinone reductase by dietary antioxidants: Possible role in protection against carcinogenesis and toxicity
8. The modifying influence of dichloroethylsulphide on the induction of tumours in mice by tar
9. The cocarcinogenic action of croton resin
10. Cancer prevention as a realizable goal
11. A new quantitative approach to the study of the stages of chemical carcinogenesis in the mouse's skin
12. Australian antigen and the biology of hepatitis B
13. Enhancement of azo dye carcinogenesis by dietary sodium sulfate
14. 1′‐Hydroxysafrole, a proximate carcinogenic metabolic of safrole in the rat and mouse
15. The metabolism of the naturally occurring hepatocarcinogen safrole to 1′‐ hydroxysafrole and the electrophilic reactivity of 1′‐acetoxysafrole
16. Metabolic conversion of benzo(a)pyrene by Syrian hamster liver microsomes and binding of metabolites to deoxy‐ ribonucleic acid
17. The function and mechanism of promoters of carcinogenesis
18. Biochemical mechanism of tumor promotion
19. The biological significance of metabolism of polycyclic compounds
20. Mechanism of the carcinogenicity of polycyclic hydrocarbons
21. The metabolism of methylated aminoazo dyes. IV. Dietary factors enhancing demethylationin vitro
22. Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8‐diol‐9,10‐epoxides in newborn mice: Exceptional activity of (+)‐7β,8α‐dihydroxy‐9α,10α‐epoxy‐7,8,9,10‐tetrahydrobenzo[a]pyrene
23. Cancer of the scrotum in chimney sweeps and others. II. Why foreign sweeps do not suffer from scrotal cancer
24. 4 to microsomal lipids in rats under varying experimental conditions
25. Metabolic activation of aromatic hydrocarbons by one‐electron oxidation in relation to the mechanism of tumor initiation
26. On the etiology of some human cancers
27. Pharmacological implications of microsomal enzyme induction
28. The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3‐methylcholanthrene
29. Substrate‐induced synthesis and other properties of benzypyrene hydroxylase in rat liver
30. Regulation of drug metabolism in man by environmental chemicals and diet
31. N‐Hydroxylation: A new metabolic reaction observed in the rat with the carcinogen 2‐acetylaminofluorene
32. N‐Hydroxy‐2‐acetylamino‐fluorene sulfotransferase: Its probable role in carcinogenesis and protein‐(methion‐S‐yl)‐binding in rat liver
33. Sulfotransferase activation of N‐hydroxy‐2‐acetylaminofluorene in rodent livers susceptible and resistant to this carcinogen
34. Reactivity in vivo of the carcinogen N‐hydroxy‐2‐acetylaminofluorene: Increase by sulfate ion
35. Viruses as causes of some human tumors? Results and prospectives of the epidemiologic approach
36. The epidemiology of cancer
37. The hepatocarcinogenicity of estragole (1‐allyl‐4‐methoxybenzene) and 1′‐hydroxyestragole in the mouse and the mutagenicity of 1′‐ acetoxyestragole in bacteria
38. Reactivity of the diacetyl derivative of the carcinogen 4‐hydroxyaminoquinoline‐1‐oxide with DNA, RNA, and other nucleophiles
39. Carcinogenicity testing of selected food additives by parenteral administration to infant Swiss mice
40. 1in vitro
41. Ethionine carcinogenesis
42. Inhibition of the metabolism of the colon carcinogen, azoxymethane, by pyrazole
43. Possible role of 6‐hydroxymethyl‐benzo(a)pyrene as a proximate carcinogen of benzo(a)pyrene and 6‐methylbenzo(a)pyrene
44. Comparative orientation of the fluorene residue in native DNA modified by N‐acetoxy‐N‐2‐acetylaminofluorene and two 7‐halogeno derivatives
45. 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530
46. A microsome‐dependent binding of benzo(a)‐pyrene to DNA
47. Organ‐specific effects of the carcinogen methylazoxymethanol related to the metabolism by nicotinamide adenine dinucleotide‐dependent dehydrogenases
48. Mutagenic consequences of chemical reaction with DNA
49. Epoxides as microsomal metabolites of polycyclic hydrocarbons
50. Enzyme‐catalyzed reactions of polycyclic hydrocarbons with deoxyribonucleic acid and proteinin vitro
51. Conformational changes in nucleic acids modified by chemical carcinogens
52. Chemical Carcinogenesis
53. Sir Ernest Laurence Kennaway FRS, 1881–1958: Chemical causation of cancer then and today
54. Chemistry of Carcinogenic Compounds
55. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States
56. Structure‐activity relationships in diterpene esters irritant and cocarcinogenic to mouse skin
57. Diterpene ester type modulators of carcinogenesis: New findings in the mechanism of chemical carcinogenesis and in the etiology of human tumors
58. Chemical oncogenesis in culture
59. The distribution of radioactivity in the mouse following administration of dibenzanthracene labeled in the 9 and 10 positions with carbon 14
60. Occupational cutaneous cancer attributable to certain chemicals in industry
61. Present trends in cancer epidemiology
62. Perspective and future developments in research on environmental carcinogenesis
63. Metabolism of 4‐nitro‐quinoline 1‐oxide. II. In vivo conversion of subcutaneously injected 4‐nitroquinoline 1‐oxide to 4‐aminoquinoline 1‐oxide and 4‐hydroxyaminoquinoline 1‐oxide in rats
64. Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells
65. Experimental production of bladder tumors in dogs by administration of beta‐naphthylamine
66. An evaluation of chemicals and industrial processes associated with cancer in humans based on human and animal data: IARC Monographs Volumes 1 to 20
67. Persistent binding of 2‐acetylamino‐fluorene to rat liver DNA in vivo and consideration of the mechanism of binding of N‐hydroxy‐2‐acetylaminofluorene to rat liver nucleic acids
68. Reaction of the glucuronide of the carcinogen N‐hydroxy‐2‐acetylaminofluorene with nucleic acids
69. Biliary excretion of the O‐glucuronide of N‐hydroxy‐2‐acetylaminofluorene by the rat and rabbit
70. Bay‐region epoxides of dihydrodiols: A concept explaining the mutagenic and carcinogenic activity of benzo(a)pyrene and benzo(a)anthracene
71. Urothelial and hepatic DNA adducts from the carcinogen 2‐naphthylamine
72. Microsomal N‐oxidation of the hepatocarcinogen N‐methyl‐4‐aminoazobenzene and the reactivity of N‐hydroxy‐N‐methyl‐4‐aminoazobenzene
73. Hepatic metabolism of N‐hydroxy‐N‐methyl‐4‐aminoazobenzene and other N‐hydroxy arylamines to reactive sulfuric acid esters
74. Hepatic microsomal N‐glucuronidation and nucleic acid binding of N‐hydroxy arylamines in relation to urinary bladder carcinogenesis
75. 6‐arylation of DNA by the carcinogen N‐hydroxy‐1‐naphthylamine
76. 6 atom of adenine
77. Benzo(a)pyrene 7,8‐dihydrodiol is more carcinogenic than benzo(a)pyrene in newborn mice
78. Interactions between carcinogens and protein
79. Mechanism of reaction, tissue distribution, and inhibition of arylhydroxamic acid acyltransferase
80. Comparative effects of strain, species and sex on the acyltransferase‐ and sulfotransferase‐catalyzed activations of N‐hydroxy‐N‐2‐fluorenylacetamide
81. Enzyme‐catalyzed reactions of the carcinogen N‐hydroxy‐2‐fluorenylacetamide with nucleic acid
82. The role of migrant population in studies of selected cancer sites: A review
83. On the interactions of N‐2‐fluorenylhydroxylamine with nucleic acidsin vitro
84. On the mechanism of action of carcinogenic aromatic amines. I. Binding of 2‐acetylaminofluorene and N‐hydroxy‐2‐acetylaminofluorene to rat liver nucleic acids in vivo
85. Persistent binding of a new reaction product of the carcinogen N‐hydroxy‐2‐acetylaminofluorene with guanine in rat liver DNA in vivo
86. 8(N‐2‐fluorenyl‐acetamido)‐guanosine, an arylamidation reaction product of guanosine and the carcinogen N‐acetoxy‐N‐2‐fluorenylacetamide in neutral solution
87. Metabolic activation of aromatic amines and amides and interactions with nucleic acids
88. Trichloromethane free radical formation from carbon tetrachloride by liver microsomes: A reductive or homolytic cleavage?
89. Binding of K‐region epoxides and other derivatives of benz(a)anthracene and dibenz(a, h)anthracene to DNA, RNA, and proteins of transformable cells
90. Apparition de cancers de la mamelle chez la souris male, soumise a des injections de folliculine
91. Some additive effects of carcinogenic hydrocarbons
92. Carcinogenesis by alkylating agents
93. Approaches to chemical dosimetry in mutagenesis and carcinogenesis: The relevance of reactions of chemical mutagens and carcinogens with DNA
94. Marked differences in the tumor‐initiating activity of optically pure (+)‐ and (‐)‐ trans‐7,8‐dihydroxy‐7,8‐dihydrobenzo(a)pyrene on mouse skin
95. Studies on structures of polar dyes derived from the liver proteins of rats fed N‐methyl‐4‐amino‐azobenzene. II. Identity of synthetic 3‐(homocystein‐S‐yl)‐N‐methyl‐4‐aminoazobenzene with the major polar dye P2b
96. Studies on structures of polar dyes derived from the liver proteins of rats fed N‐methyl‐4‐amino‐azobenzene. III. Tyrosine and homocysteine sulfoxide polar dyes
97. Structures of hepatic nucleic acid‐bound dyes in rats given the carcinogen N‐methyl‐4‐amino‐azobenzene
98. 1‐DNA or ‐rRNA adducts formed in hepatic microsome‐mediated reactions and in rat liver in vivo
99. N‐Substitution of C‐8 in guanosine and deoxyguanosine by the carcinogen N‐benzoyloxy‐N‐methyl‐4‐aminoazobenzenein vitro
100. Metals and genetic miscoding
101. Reaction of esters of aromatic N‐hydroxy amines and amides with methionine in vitro: A model for in vivo binding of amine carcinogens to protein
102. Possible relevance of O‐6 alkylation of deoxy‐guanosine to the mutagenicity and carcinogenicity of nitrosamines and nitrosamides
103. N‐nitroso compounds and related carcinogens
104. DNA repair and carcinogenesis
105. Mutations and decreases in density of transforming DNA produced by derivatives of the carcinogens 2‐acetylaminofluorene and N‐methyl‐4‐aminoazobenzene
106. Evidence for a receptor protein of activated carcinogen
107. Cancer: The survival of the fittest
108. The apparent binding of radioactive 2‐acetylaminofluorene to rat‐liver ribonucleic acid in vivo
109. 14
110. 1 causes guanine substitution in nucleic acids
111. Studies on methylazoxymethanol, the aglycone of cyasin: Methylation of nucleic acidsin vitro
112. Toxicity of pyrrolizidine alkaloids
113. Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals. Discussion
114. The detection of carcinogens as mutagens in the Salmonella microsome test: Assay of 300 chemicals
115. Oncogenic purine N‐oxide derivatives as substrates for sulfotransferase
116. Studies on the formation of protein‐bound derivatives of 3,4‐benzpyrene in the epidermal fraction of mouse skin
117. Some current perspectives on chemical carcinogens in humans and experimental animals: Presidential address
118. The carcinogenicity of p‐mono‐methylaminoazobenzene in various diets and the activity of this dye relative to p‐dimethylaminoazobenzene
119. Nucleic acid guanine: Reaction with the carcinogen N‐acetoxy‐2‐acetylaminofluorene
120. Reactions in vitro of some tissue nucleophiles with the glucuronide of the carcinogen N‐hydroxy‐2‐acetylaminofluorene
121. N‐Hydroxy metabolites of 2‐acetylaminophenanthrene and 7‐fluoro‐2‐acetylaminofluorene as proximate carcinogens in the rat
122. The presence and significance of bound aminoazo dyes in the livers of rats fed p‐dimethylaminoazobenzene
123. In vivo combinations between carcinogens and tissue constituents and their possible role in carcinogenesis
124. Biochemical investigations in hepatic carcinogenesis
125. Mechanisms of chemical carcinogenesis: Nature of proximate carcinogens and interactions with macromolecules
126. The mutagenicity of chemical carcinogens: Correlations, problems, and interpretations
127. The comparative carcinogenicities of 2‐acetylaminofluorene and its N‐hydroxy metabolite in mice, hamsters, and guinea pigs
128. N‐Hydroxy‐2‐acetyl‐aminofluorene: A metabolite of 2‐acetylaminofluorene with increased carcinogenic activity in the rat
129. Studies on the protein‐bound aminoazo dyes formed in vivo from 4‐dimethyl‐aminoazobenzene and its C‐monomethyl derivatives
130. The carcinogenicity of certain azo dyes related to p‐dimethylaminoazobenzene
131. The N‐ and ring‐hydroxylation of 2‐acetylaminofluorene during carcinogenesis in the rat
132. The carcinogenicity of certain derivatives of p‐dimethylaminoazobenzene in the rat
133. The carcinogenic aminoazo dyes
134. The activation of carcinogenic aromatic amines and amides by N‐hydroxylation in vivo
135. Metabolic activation of carcinogenic aromatic amines and amides via N‐hydroxylation and N‐hydroxy esterification and its relationship to ultimate carcinogens as electrophilic reactants
136. The metabolic activation of carcinogenic aromatic amines and amides
137. The metabolic activation of safrole and related naturally occurring alkenylbenzenes in relation to carcinogenesis by these agents
138. The N‐hydroxylation of 4‐acetylaminobiphenyl by the rat and dog and the strong carcinogenicity of N‐hydroxy‐4‐acetylaminobiphenyl in the rat
139. Genetic mosaicism and in vivo analyses of neoplasia and differentiation
140. Normal genetically mosaic mice produced from malignant teratocarcinoma cells
141. A developing factor in experimental blasto‐genesis
142. The metabolism of 4‐dimethyl‐aminoazobenzene by rat liver homogenates
143. The reductive cleavage of 4‐dimethyl‐aminoazobenzene by rat liver: The intracellular distribution of the enzyme system and its requirement for triphosphopyridine nucleotide
144. International variation in high‐risk populations
145. Genetic variation in metabolism of chemical mutagens associated with susceptibility to tumorigenesis
146. N‐Nitroso compounds: Biochemical mechanisms of action
147. Identification of tertiary aminomethylenedioxypropiophenones as urinary metabolites of safrole in the rat and guinea pig
148. Dietary aflatoxins and human liver cancer. A study in Swaziland
149. Studies of the ethylation of rat liver transfer ribonucleic acid after administration of L‐ethionine
150. Structures of the DNA adducts formed in mouse liver after administration of the proximate hepatocarcinogen 1′‐hydroxyestragole
151. Morphological transformation of early passage golden Syrian hamster embryo cells derived from cryopreserved primary cultures as a reliable in vitro bioassay for identifying diverse carcinogens
152. Differentiation of normal and malignant cells
153. Tumorigenicity of embryonal carcinoma as an assay to study control of malignancy by the murine blastocyst
154. The stages of initiation and promotion in hepatocarcinogenesis
155. N‐Benzoyloxy‐ N‐methyl‐4‐aminoazobenzene: Its carcinogenic activity in the rat and its reactions with proteins and nucleic acids and their constituentsin vitro
156. Percivall Pott's contribution to cancer research. (including a reproduction of Pott's original article)
157. Carcinogene Wirkung von Phenyl‐nitroso‐harnstoff
158. Chemical structure and carcinogenicity of aliphatic hydrazo, azo, and azoxycompounds and of triazenes, potential in vivo alkylating agents
159. An evaluation of 6 short‐term tests for detecting organic chemical carcinogens
160. The primary aromatic amines: Their biological properties and structure‐activity relationships
161. Bladder cancer induction by aromatic amines: Roles of N‐hydroxy metabolites
162. Isolation of the glucuronic acid conjugate of N‐hydroxy‐4‐aminobiphenyl from dog urine and its mutagenic activity
163. Tobacco and cancer: The first clinical report, 1761
164. Blasengeschwülste bei Fuchsin‐Arbeitern
165. Liver tumor inhibition and adrenal histologic responses in rats to which 3′‐methyl‐4‐dimethylaminoazobenzene and 20‐methylcholanthrene were simultaneously administered
166. Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system
167. 2 by animal and human liver
168. Conditional neoplasms and subthreshold neoplastic states: A study of the tar tumors of rabbits
169. Is somatic mutation the major mechanism of malignant transformation?
170. Mutagenic activation of N‐hydroxy‐2‐acetylaminofluorene in the Salmonella test system: The role of deacetylation by liver and kidney fractions from mouse and rat
171. 3‐Methylmercapto‐ N‐methyl‐4‐aminoazobenzene: An alkaline‐degradation product of a labile protein‐bound dye in the livers of rats fed N, N‐dimethyl‐4‐aminoazobenzene
172. An epoxide is an intermediate in the microsomal metabolism of the chemical carcinogen, dibenz(a, h)anthracene
173. Metabolic activation of benzo(a)pyrene proceeds by a diol‐epoxide
174. The biosynthesis and biological properties of 6‐hydroxymethylbenzo(a)pyrene
175. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)
176. The metabolism of safrole and 2′,3′‐epoxysafrole in the rat and guinea pig
177. Oncogenic purine derivatives: Evidence for a possible proximate oncogen
178. The metabolism of 4‐nitroquinoline 1‐oxide, a carcinogen. I. Conversion of 4‐nitro‐quinoline 1‐oxide to 4‐aminoquinoline 1‐oxide by rat liver enzymes
179. Overlapping of carcinogens and mutagens
180. Evidence for ethylation of rat liver deoxyribonucleic acid after administration of ethionine
181. 2 to rat liver DNA and ribosomal RNA in vivo
182. 1‐2,3‐oxide: Evidence for its formation in rat liver in vivo and by human liver microsomesin vitro
183. 1 adduct formed by hamster and rat liver microsomesin vitro
184. 1
185. Metabolic activation of 4‐nitroquinoline 1‐oxide and its binding to nucleic acid
186. Nutrition and cancer
187. Adducts from the reaction of N‐benzoyloxy‐ N‐methyl‐4‐aminoazobenzene with deoxyguanosine or DNA in vitro and from hepatic DNA of mice treated with N‐methyl‐ or N, N‐dimethyl‐4‐aminoazobenzene
188. Radiation effects
189. Genetic and environmental interactions in skin carcinogenesis
190. Tumor‐promoting and co‐carcinogenic agents in chemical carcinogenesis
191. Primary liver cancer rate and aflatoxin intake in a high cancer area
192. Aromatic amines as carcinogens in industry
193. 1 modified deoxyribonucleic acidin vitro
194. Molecular structure of nucleic acids: A structure for deoxyribose nucleic acid
195. Inhibitors of chemical carcinogenesis
196. Structural and functional changes in nucleic acids modified by chemical carcinogens
197. Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo
198. Molecular and cellular events associated with the action of initiating carcinogens and tumor promoters
199. Chemistry, carcinogenicity and metabolism of 2‐fluorenamine and related compounds
200. On the sulfate ester of N‐hydroxy‐ N‐2‐fluorenylacetamide as a key ultimate hepatocarcinogen in the rat
201. Identification of the persistently bound form of the carcinogen N‐acetyl‐2‐aminofluorene to rat liver DNA in vivo
202. On the binding of the carcinogen 2‐acetyl‐aminofluorene to rat liver RNA and DNA
203. The metabolic activation of the carcinogen 1′‐hydroxysafrole in vivo and in vitro and the electrophilic reactivities of possible ultimate carcinogens
204. Carcinogenic and mutagenic activities of safrole, 1′‐hydroxy‐safrole and some known or possible metabolites
205. Structure‐activity relationships in toxicity and carcinogenicity of aflatoxins and analogs
206. Experimental study of the pathogenesis of carcinoma
207. 2 guanosine adducts of N‐acetyl‐2‐amino‐fluorene by single strand‐specific endo‐nucleases
208. Über die serienweise Verfolgung der Veränderungen der Leber der experimentellen Hepatomerzeugung durch o‐Aminoazotoluol